Regenerative Medicine

Understanding the Safety of Mesenchymal Stromal Cell Therapy

Mesenchymal stromal cell therapy, often called MSC therapy, has become one of the most widely studied approaches in regenerative and cellular medicine. Over the past two decades, researchers have explored its potential to treat a wide range of inflammatory and immune-related conditions, including heart disease, lung injury, autoimmune disorders, and complications following cancer treatment. As…

Mesenchymal Stromal Cell Therapy: Current Evidence, Challenges, and Future Directions

Mesenchymal stromal stem cells, commonly called MSCs, have been among the most-studied cell types in regenerative medicine over the past two decades. They have been tested in hundreds of clinical trials for conditions ranging from joint degeneration to heart disease, autoimmune disorders, lung injury, and complications after transplantation. MSCs have consistently been shown to be…

Spinal Cord Injury and Regenerative Medicine: Exploring Stem Cell Therapy Benefits

If you or someone you care about has been diagnosed with a spinal cord injury, you understand how life-altering the challenges can be. At Stemedix, we work with patients who have already received a confirmed diagnosis and are seeking alternative ways to support their recovery goals. While no treatment guarantees a cure, regenerative medicine offers…

Mesenchymal Stem Cell Therapy for Disc-Related Low Back Pain: Current Evidence

Low back pain is one of the most common health problems worldwide. It affects quality of life, limits work and daily activities, and creates a significant economic burden. In many adults, especially those over age 50, a key driver of this pain is lumbar intervertebral disc degeneration. When the disc between the vertebrae begins to…

Regenerative Pathways in Aging: The Role of Mesenchymal Stem Cells

Aging is a universal biological process marked by the gradual decline of physiological function across all organ systems. It is driven by a combination of genetic, environmental, and molecular factors that influence the rate of deterioration from birth onward. Although inevitable, scientific progress in regenerative medicine has identified potential ways to mitigate its effects and…

Mesenchymal Stromal Cell–Derived Extracellular Vesicles: A Promising Therapeutic Strategy for Pulmonary Fibrosis

Pulmonary fibrosis is a chronic and progressive lung disease marked by abnormal scarring of the tissue surrounding the air sacs. This process thickens and stiffens the lungs, leading to shortness of breath, fatigue, and reduced oxygen exchange. Current medications, such as pirfenidone and nintedanib, can slow disease progression but do not reverse tissue damage. As…

Lifestyle Foundations That Support Regenerative Medicine

Regenerative medicine focuses on helping the body repair, restore, and heal at a deeper level. But for these therapies to work at their best, your body needs a supportive foundation; the daily habits that strengthen your cells, lower inflammation, and create an environment where healing can truly take place. Think of regenerative treatments as seeds.…

Mesenchymal Stem Cells in Regenerative Medicine: Mechanisms, Clinical Progress, and Future Directions

Mesenchymal stem cells (MSCs) are at the forefront of regenerative medicine, offering significant therapeutic potential due to their self-renewal, multipotency, and immunomodulatory properties. These nonhematopoietic adult stem cells can differentiate into various mesodermal lineages, including bone, cartilage, and adipose cells, while influencing immune and inflammatory pathways.  As part of this review, Han et al. explore…

Mesenchymal Stem Cells as a Therapeutic Approach for Alzheimer’s Disease

Alzheimer’s disease (AD) is the most common cause of dementia, gradually destroying memory, learning, and functional independence. Current FDA-approved drugs such as donepezil, rivastigmine, galantamine, and memantine provide limited symptomatic relief but do not slow the progression of neuronal loss. Antibody therapies that target amyloid plaques have shown inconsistent clinical outcomes. As a result, researchers…

Mesenchymal Stem Cells: A New Hope for Parkinson’s Disease

Parkinson’s disease (PD) is one of the most common neurodegenerative conditions, second only to Alzheimer’s. It primarily affects the basal nuclei of the brain, leading to the gradual loss of dopamine-producing neurons and the buildup of abnormal protein clusters called Lewy bodies. Together, these changes cause the classic motor and cognitive symptoms of the disease.…

Load More

Do you have questions?

We have answers. Speak with a Stemedix Care Coordinator today with no obligation. Give us a call!

Contact Us
Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.